Dr Samuel Blackman

Samuel C. Blackman, MD, PhD

Chief Medical Officer & Co-Founder

Day One Biopharmaceuticals

Brenda Weigel

Brenda Weigel, MD

Director of the Division of Pediatric Hematology/Oncology

University of Minnesota's Masonic Cancer Center


Peter Adamson, MD


Elizabeth Fox, MD, MS

St. Jude Children's Research Hospital

Mark Kieran, MD, PhD

Bristol Myers Squibb

Sabine Mueller, MD, PhD

University of California, San Francisco

Lou Stancato, PhD

Eli Lilly and Company

Mark Turner, BSc, PhD, MBChB, MRCP(UK), MRCPCH, DRCOG, FFPM(Hon)

University of Liverpool, conect4children


Expanding the Global Footprint of Pediatric Oncology Trials

  • Derek Ansel, MS, CCRA
    Worldwide Clinical Trials 

  • Guillermo Chantada, MD
    Hospital Sant Joan de Déu Barcelona 

  • Sae Ishimaru, MD, PhD
    Princess Maxima Center 

  • Chi-kong Li, MBBS, MD, FRCPCH, FHKAM (Paediatrics), JP
    The Chinese University of Hong Kong 

  • Heidi Wang, PhD
    Bristol Myers Squibb 

Real-World Data and Synthetic Control Arms

  • Pallavi Mishra-Kalyani, PhD
    U.S. Food and Drug Administration 

  • Samuel Volchenboum, MD, PhD
    University of Chicago 

  • Barbara Arone, MS
    IQVIA Real World Solutions 

Pharmacokinetics in pediatric clinical trial design: How do we find the “right” dose?

  • Gilbert J. Burckart, PharmD
    U.S. Food and Drug Administration 

  • Gareth Veal, PhD
    Newcastle University 

  • S.Y. Amy Cheung, PhD

Clinical Trials with Combination Therapies

  • Cassie Kline, MD, MS
    Children’s Hospital of Philadelphia 

  • Jeffrey Skolnik, MD
    Inovio Pharmaceuticals, Inc. 

  • Elizabeth R. Lawlor, MD, PhD
    Seattle Children’s Hospital 

Decentralized Clinical Trials

  • Isaac R. Rodriguez-Chavez, PhD, MHSc, MSc
    ICON plc.

Regulators Dish

  • Gregory Reaman, MD
    U.S. Food and Drug Administration 

  • Dominik Karres, MD
    European Medicines Agency 

Please check in regularly as we update our speaker list. 

Pin It on Pinterest

Scroll to Top